| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1987PNAS...84.5158O |
| P356 | DOI | 10.1073/PNAS.84.15.5158 |
| P932 | PMC publication ID | 298813 |
| P698 | PubMed publication ID | 3037537 |
| P5875 | ResearchGate publication ID | 20117818 |
| P2093 | author name string | M J Murray | |
| F J Grant | |||
| P J O'Hara | |||
| F S Hagen | |||
| C L Gray | |||
| B A Haldeman | |||
| M Y Insley | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| The nucleotide sequence of the gene for human protein C | Q24613144 | ||
| Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation | Q24629960 | ||
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs | Q27860573 | ||
| A catalogue of splice junction sequences | Q27860696 | ||
| Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ | Q27860770 | ||
| Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination | Q27860827 | ||
| Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I | Q27860885 | ||
| A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S | Q28262397 | ||
| Nucleotide sequence of the gene for human factor IX (antihemophilic factor B) | Q28646323 | ||
| Characterization of a cDNA coding for human factor VII | Q28646329 | ||
| Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro | Q28646818 | ||
| Patterns of amino acids near signal-sequence cleavage sites | Q29616542 | ||
| Why genes in pieces? | Q29618207 | ||
| Transcription termination and 3' processing: the end is in site! | Q29618288 | ||
| The isolation of structural genes from libraries of eucaryotic DNA | Q29618452 | ||
| The gene structure of human anti-haemophilic factor IX. | Q33939512 | ||
| Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. | Q34190061 | ||
| Hypervariable 'minisatellite' regions in human DNA. | Q34192489 | ||
| Three different fibronectin mRNAs arise by alternative splicing within the coding region | Q34708457 | ||
| Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation | Q35047906 | ||
| Evolution and organization of the human protein C gene | Q35587591 | ||
| The consensus sequence YGTGTTYY located downstream from the AATAAA signal is required for efficient formation of mRNA 3' termini | Q36136653 | ||
| Variation in the polyadenylylation site of bovine prolactin mRNA. | Q36275652 | ||
| The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors | Q36487707 | ||
| Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin | Q36597580 | ||
| Identification of a sequence element on the 3' side of AAUAAA which is necessary for simian virus 40 late mRNA 3'-end processing. | Q36894844 | ||
| Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele | Q37395197 | ||
| The Role of Serine Proteases in the Blood Coagulation Cascade | Q39784389 | ||
| Evolution of Proteolytic Enzymes | Q40173671 | ||
| Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII | Q40306238 | ||
| Use of unpurified synthetic deoxynucleotide primers for rapid dideoxynucleotide chain termination sequencing | Q44108378 | ||
| Amino acid sequence of bovine protein Z: a vitamin K-dependent serine protease homolog | Q44257556 | ||
| Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene | Q48379485 | ||
| Alternative RNA splicing in expression of the H-2K gene | Q48394384 | ||
| Alternative splicing caused by RNA secondary structure. | Q54198854 | ||
| Evolution of Repeated DNA Sequences by Unequal Crossover | Q56094996 | ||
| Are U4 small nuclear ribonucleoproteins involved in polyadenylation? | Q59062270 | ||
| Isolation and Expression of cDNAs Encoding Human Factor VII | Q61314314 | ||
| Promoter sequences of eukaryotic protein-coding genes | Q64381722 | ||
| Mutations downstream of the polyadenylation site of a Xenopus beta-globin mRNA affect the position but not the efficiency of 3' processing | Q69882952 | ||
| Speculations on RNA splicing | Q70756413 | ||
| Enhanced glycogen repletion in liver and skeletal muscle with citrate orally fed after exhaustive treadmill running and swimming | Q71769522 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| vitamin K | Q182338 | ||
| coagulation factor VII | Q412850 | ||
| serine-type peptidase activity | Q14326101 | ||
| P304 | page(s) | 5158-62 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation | |
| P478 | volume | 84 |
| Q71999915 | A NlaIII polymorphism within the human factor VII gene |
| Q59697020 | A Polymorphic Cluster in the 5′ Region of the Human Coagulation Factor VII Gene: Detection, Frequency, and Linkage Disequilibrium |
| Q30824756 | A mammalian homologue of a transcript from the Drosophila pecanex locus |
| Q33594403 | A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model |
| Q45865545 | A novel polymorphism in intron 1a of the human factor VII gene (G73A): study of a healthy Italian population and of 190 young survivors of myocardial infarction |
| Q72947713 | A polymorphism in the 5' region of coagulation factor VII gene (F7) caused by an inserted decanucleotide |
| Q42224211 | An engineered U1 small nuclear RNA rescues splicing defective coagulation F7 gene expression in mice. |
| Q73786779 | Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency |
| Q28397726 | Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis |
| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q40242591 | Characterization of a Cys329Gly mutation causing hereditary factor VII deficiency |
| Q38340699 | Characterization of transcriptional regulatory elements in the promoter region of the murine blood coagulation factor VII gene |
| Q57987850 | Circadian Rhythms in Mouse Blood Coagulation |
| Q68214111 | Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) |
| Q45888396 | Development of a transgenic mouse model with immune tolerance for human coagulation factor VIIa |
| Q37711731 | Epidermal growth factor-like domains in the vitamin K-dependent clotting factors. Some structure-function relationships |
| Q36674600 | Evolution of prothrombin: isolation and characterization of the cDNAs encoding chicken and hagfish prothrombin |
| Q34786241 | Factor VII Deficiency |
| Q64075447 | Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications |
| Q24322691 | Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity |
| Q25255539 | Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature |
| Q34119225 | Factor VII deficiency and the FVII mutation database |
| Q39569848 | Factor VII deficiency due to compound heterozygosity for Leu-48Pro mutation and a novel Pro260Leu mutation |
| Q47164838 | Factor VII deficiency: a novel missense variant and genotype-phenotype correlation in patients from Southern Italy |
| Q41976376 | Factor VII mutant V154G models a zymogen-like form of factor VIIa. |
| Q47642467 | Fish as bioreactors: transgene expression of human coagulation factor VII in fish embryos. |
| Q90573716 | Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII |
| Q38362641 | Functional characterization of the human factor VII 5'-flanking region |
| Q33835076 | Genotype and phenotype correlation in intracranial hemorrhage in neonatal factor VII deficiency among Thai children |
| Q45888005 | Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency. |
| Q45881281 | Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity |
| Q35581311 | Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. |
| Q46448751 | High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa |
| Q42070531 | Highly conserved residue arginine-15 is required for the Ca2+-dependent properties of the gamma-carboxyglutamic acid domain of human anticoagulation protein C and activated protein C. |
| Q44103806 | Human factor VII deficiency caused by S339C mutation located adjacent to the specificity pocket of the catalytic domain |
| Q36478404 | Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia |
| Q24564490 | Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice |
| Q34444907 | Invited review: Pharmacogenetics of estrogen replacement therapy |
| Q38329413 | Liver-specific expression of the gene coding for human factor X, a blood coagulation factor |
| Q28610828 | Liver-specific expression of the human factor VII gene |
| Q84969518 | Management of kidney transplantation in a factor VII-deficient patient: case report |
| Q54981028 | Molecular Characterization of Iranian Patients with Inherited Coagulation Factor VII Deficiency. |
| Q38905795 | Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. |
| Q34304894 | Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain |
| Q64240568 | Neutrophil extracellular trap components increase the expression of coagulation factors |
| Q33256107 | Oriented scanning is the leading mechanism underlying 5' splice site selection in mammals |
| Q38291133 | Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter |
| Q40506382 | PCR detection of a repeat polymorphism within the F7 gene |
| Q35224536 | Possibilities of DNA analysis for the detection of predisposition to thrombotic disease |
| Q40545903 | Probing the human genome with minisatellite-like sequences from the human coagulation factor VII gene |
| Q45858909 | Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. Importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa |
| Q35852300 | Recombinant biologics for treatment of bleeding disorders |
| Q45887032 | Role of the 2 adenine (g.11293_11294insAA) insertion polymorphism in the 3' untranslated region of the factor VII (FVII) gene: molecular characterization of a patient with severe FVII deficiency. |
| Q36748672 | Similarity landscapes: a way to detect many structural and sequence motifs in both introns and exons |
| Q41263894 | Structural analysis of the uEGF gene in the sea urchin strongylocentrotus purpuratus reveals more similarity to vertebrate than to invertebrate genes with EGF-like repeats |
| Q36889043 | Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa. |
| Q53889666 | Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VII. |
| Q54575982 | The effects of three factor VII polymorphisms on factor VII coagulant levels in healthy Singaporean Chinese, Malay and Indian newborns. |
| Q67532710 | The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor |
| Q52527775 | The gamma-carboxylation recognition site is sufficient to direct vitamin K-dependent carboxylation on an adjacent glutamate-rich region of thrombin in a propeptide-thrombin chimera. |
| Q40519633 | The hemophilias. |
| Q38230901 | The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery |
| Q35843460 | The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots |
| Q45874481 | The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort |
| Q47788839 | Tissue factor and biotechnology. |
| Q35684155 | Tissue factor: a key molecule in hemostatic and nonhemostatic systems |
| Q36798033 | Transcriptional regulation of the gene coding for human protein C. |
| Q74127817 | Two new missense mutations (P134T and A244V) in the coagulation factor VII gene |
| Q45872643 | Two novel factor VII gene mutations in a Chinese family with factor VII deficiency |
| Q86941742 | [Genetic diagnosis and bioinformatic analysis of a pedigree with inherited factor VII deficiency] |
Search more.